Right Ventricle to Pulmonary Artery Conduit Size Is Associated With Conduit and Pulmonary Artery Reinterventions After Truncus Arteriosus Repair

Author(s):  
Carlos Bonilla-Ramirez ◽  
Christopher Ibarra ◽  
Ziyad M. Binsalamah ◽  
Iki Adachi ◽  
Jeffrey S. Heinle ◽  
...  
2021 ◽  
Vol 12 (3) ◽  
pp. 406-410
Author(s):  
Vijayakumar Raju ◽  
Chandrasekar Padmanabhan ◽  
Christopher W. Baird

The modified Ozaki technique within a conduit is reproducible and is an alternative to the use of homografts and commercially available conduits which may have special appeal in a low resource setting.


2007 ◽  
Vol 49 (4) ◽  
pp. 480-484 ◽  
Author(s):  
Sanjeev Aggarwal ◽  
Swati Garekar ◽  
Thomas J. Forbes ◽  
Daniel R. Turner

2009 ◽  
Vol 4 (6) ◽  
pp. 433-439 ◽  
Author(s):  
Tarak Desai ◽  
Oliver Stumper ◽  
Paul Miller ◽  
Rami Dhillon ◽  
John Wright ◽  
...  

2014 ◽  
Vol 25 (6) ◽  
pp. 1119-1123 ◽  
Author(s):  
Christopher J. Knott-Craig ◽  
Thittamaranahalli Kariyappa S. Kumar ◽  
Alejandro R. Arevalo ◽  
Vijaya M. Joshi

AbstractObjective:Symptomatic neonates with Ebstein’s anomaly pose significant challenge. Within this cohort, neonates with associated anatomical pulmonary atresia have higher mortality. We review our experience with this difficult subset.Methods:A total of 32 consecutive symptomatic neonates with Ebstein’s anomaly underwent surgical intervention between 1994 and 2013. Of them, 20 neonates (62%, 20/32) had associated pulmonary atresia. Patients’ weights ranged from 1.9 to 3.4 kg. All patients without pulmonary atresia had two-ventricle repair. Of the 20 neonates, 16 (80%, 16/20) with Ebstein’s anomaly and pulmonary atresia had two-ventricle repair and 4 had single-ventricle palliation, of which 2 underwent Starnes’ palliation and 2 Blalock–Taussig shunts. Six recent patients with Ebstein’s anomaly and pulmonary atresia had right ventricle to pulmonary artery valved conduit as part of their two-ventricle repair.Results:Overall early mortality was 28% (9/32). For those without pulmonary atresia, mortality was 8.3% (1/12). For the entire cohort of neonates with Ebstein’s anomaly and pulmonary atresia, mortality was 40% (8/20; p=0.05). Mortality for neonates with Ebstein’s anomaly and pulmonary atresia having two-ventricle repair was 44% (7/16). Mortality for neonates with Ebstein’s anomaly and pulmonary atresia having two-ventricle repair utilising right ventricle to pulmonary artery conduit was 16% (1/6). For those having one-ventricle repair, the mortality was 25% (1/4).Conclusions:Surgical management of neonates with Ebstein’s anomaly remains challenging. For neonates with Ebstein’s anomaly and anatomical pulmonary atresia, single-ventricle palliation is associated with lower early mortality compared with two-ventricle repair. This outcome advantage is negated by inclusion of right ventricle to pulmonary artery conduit as part of the two-ventricle repair.


2007 ◽  
Vol 28 (2) ◽  
pp. 122-125 ◽  
Author(s):  
Richard G. Ohye ◽  
Eric J. Devaney ◽  
Jennifer C. Hirsch ◽  
Edward L. Bove

2019 ◽  
Vol 10 (4) ◽  
pp. 499-501
Author(s):  
Teimour Nasirov ◽  
Katsuhide Maeda ◽  
Olaf Reinhartz

Background: Several modifications of the Norwood procedure utilizing valved right ventricle to pulmonary artery conduits have recently been reported. Our group has been using aortic or pulmonary valved homografts combined with PTFE tube grafts for now 16 years. Methods: In this report, we review our technique in detail and describe any changes that have occurred over the years. We provide detailed illustrations of our preferred surgical technique, report outcome data, and compare it to the other conduit options available. Results: Between 2006 and 2015, 130 stage I Norwood procedures were performed at our institution, 100 of them using valved conduits. Our technique is described and illustrated in detail. Early mortality was 15%. Postoperative percutaneous intervention on the conduit was required in 29% of cases. Conclusions: While a randomized trial comparing different valved conduits is lacking, we believe a composite conduit made from homograft aortic or pulmonary valves and PTFE tube grafts is an excellent choice in stage I Norwood procedure.


2015 ◽  
Vol 149 (6) ◽  
pp. 1502-1508.e1 ◽  
Author(s):  
James R. Bentham ◽  
Christopher W. Baird ◽  
Deigo P. Porras ◽  
Rahul H. Rathod ◽  
Audrey C. Marshall

Sign in / Sign up

Export Citation Format

Share Document